JT Pharmaceuticals - kappa opioid agonist peptide - Ownership and Business Overview

Life ScienceCompany

JT Pharmaceuticals - kappa opioid agonist peptide Ownership

Who owns JT Pharmaceuticals - kappa opioid agonist peptide?

JT Pharmaceuticals - kappa opioid agonist peptide is owned by Titan Pharmaceuticals. It was acquired on October 28, 2020.

JT Pharmaceuticals - kappa opioid agonist peptide Business Overview

Where is JT Pharmaceuticals - kappa opioid agonist peptide headquartered?

JT Pharmaceuticals - kappa opioid agonist peptide is headquartered in Mt. Pleasant, South Carolina.

What sector is JT Pharmaceuticals - kappa opioid agonist peptide in?

JT Pharmaceuticals - kappa opioid agonist peptide is a life science company.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 290 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 267 by strategics.

JT Pharmaceuticals, Inc. - kappa opioid agonist peptide

Mt. Pleasant, South Carolina 29464
United States,

JT Pharmaceuticals, Inc.'s kappa opioid agonist peptide JT-09 is a provider of drug delivery technology, for the treatment of chronic pruritus. JT Pharmaceuticals's kappa opioid agonist peptide is based in Mt. Pleasant, South Carolina.


 Subscribe to unlock this and 208,151
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.